<!DOCTYPE html>
<!--[if IE 7]>                  <html class="ie7 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if lte IE 8]>              <html class="ie8 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--> <html class="not-ie no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">  <!--<![endif]-->
<head>
  <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="next" href="health-care-financing-administration-0.html" />
<link rel="up" href="chapter-iii-hhs-agency-evaluation-activities.html" />
<link rel="prev" href="https://aspe.hhs.gov/report/performance-improvement-1998/centers-disease-control-and-prevention-1" />
<link rel="shortcut icon" href="../../sites/default/files/Favicon2.png" type="image/png" />
<meta name="description" content="MISSION: To protect and promote public health through food, drug, medical device, and cosmetic regulation. Evaluation Program" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="food-and-drug-administration-0.html" />
<link rel="shortlink" href="https://aspe.hhs.gov/node/15831" />
<meta property="og:site_name" content="ASPE" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://aspe.hhs.gov/report/performance-improvement-1998/food-and-drug-administration-0" />
<meta property="og:title" content="Food and Drug Administration" />
<meta property="og:description" content="MISSION: To protect and promote public health through food, drug, medical device, and cosmetic regulation. Evaluation Program" />
<meta property="og:updated_time" content="2016-06-16T04:04:00-04:00" />
<meta property="article:published_time" content="2015-11-23T01:13:55-05:00" />
<meta property="article:modified_time" content="2016-06-16T04:04:00-04:00" />

  <title>Food and Drug Administration | ASPE</title>
	<meta http-equiv="X-UA-Compatible" content="IE=edge"><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1026.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>

	<!-- Mobile Specific Metas
	================================================== -->
	<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=0">

  <link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__5ln8neBOcJfyUveiD4y9fhI6kHBLOQ_YL0mMC-LS9a0__TPJIZT9UBnf_685NlFTJ5KnZVsjwFk6ACQ-nwwygmwU__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__ng49uRH5y4Hl9VF9hHW_vXOj-mcOc2u2ShJqJ1YKIGU__FoMCD14GBvZaRiqSQ_JpP1w3rDB21n7H2Ar4pRZaIh8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__Hskudx14OJ5Hz8vqU7CUgN6SDV5rINZuEq9VuGsSeyc__EwNIl3xeFrniW2TmonovTzhSs3X5MdFps210puE7jog__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__9rZoaX9BdzjjNucvYxduxeNAVO2zgW_Rvjhb5rq5whc__lSr_y16grDSgHf4booPChnF7QXz3TQY3hafH49twE0k__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__ZgfI_ZPib5yVY0o5aKo_6TFn946Tuu_nFDa0ySTmkSc__2FTFrNw2eNh0mpHIOA34r6YRwBZMm2PjJ_JubnwLigg__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__dxabpJ5rQgDSixKgLJZjWc1beC6mpROKwVrmWxI5eno__rqhz_hGsE_i59O7-W991o71_Jxw1QOtGMxn4nsOLHY8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../../sites/default/files/advagg_css/css__ZbRCq2NqWgK-HXAQI3So0N1n0nr4HonsJS3eQuuxukw__7Olkk8Locn8Dj0eR0Ww3rbV9lks9sxipcboMXB18RRs__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />

	<!-- Head Libs -->
	<script src="../../sites/all/themes/stability/stability_aspe/vendor/modernizr.js"></script>

	<!--[if lt IE 9]>
		<script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
		<script src="/sites/all/themes/stability/vendor/respond.min.js"></script>
	<![endif]-->

	<!-- Favicons
	================================================== -->
	<link rel="apple-touch-icon" href="../../sites/all/themes/stability/images/apple-touch-icon.png">
	<link rel="apple-touch-icon" sizes="72x72" href="../../sites/all/themes/stability/images/apple-touch-icon-72x72.png">
	<link rel="apple-touch-icon" sizes="114x114" href="../../sites/all/themes/stability/images/apple-touch-icon-114x114.png">
	<link rel="apple-touch-icon" sizes="144x144" href="../../sites/all/themes/stability/images/apple-touch-icon-144x144.png">

</head>
<body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-15831 node-type-book">
<!-- Google Tag Manager -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-JLFR"
                  height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
  })(window,document,'script','dataLayer','GTM-JLFR');</script>
<!-- End Google Tag Manager -->
  <div id="skip-nav" class="accessibility_menu">
    <strong>Shortcut Navigation:</strong>
    <ul>
      <li><a href="food-and-drug-administration-0.html#content" accesskey="c" title="Skip to page content (ctrl/alt + c)">Page Content</a></li>
      <li><a href="food-and-drug-administration-0.html#nav" accesskey="m" title="Skip to main navigation menu (ctrl/alt + m)">Site Navigation</a></li>

      <li><a href="food-and-drug-administration-0.html#Footer" accesskey="f" title="Skip to footer (ctrl/alt + f)">Footer</a></li>
    </ul>
  </div>

    
<div class="site-wrapper">
  
  <header class="header header-menu-fullw header-top-clean">
    <div id="brand-bar">
        <div class="container">
                    <img alt='bird' src="../../sites/all/themes/stability/stability_aspe/images/bird.png"> <a target="blank" tabindex="4" href="http://www.hhs.gov/">U.S. Department of Health & Human Services</a>
        </div>

    </div>
    <div class="header-main">
        <div class="container clearfix">
            <div class="social-links-wrapper">
                <ul class="social-links social-links__light">
                                                          <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="../../sites/all/themes/stability/stability_aspe/images/tw.png"/></a></li>
                                    <!--                  --><!--                    <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin.png"/></a></li>-->
<!--                  -->
                                                                      </ul>
            </div>
            <!-- Logo -->
            <div class="logo">
                                <div class="site_name_wrapper">
                                     <span class="h1">
                                      <a href="../../images/exit_disclaimer.jpg.html">ASPE</a>
                                       </span>
                                  <p class="tagline"><p>Office of The Assistant Secretary</p><p> for Planning and Evaluation</p></p>
                    </div>
            </div>
            <!-- Logo / End -->
            <div class="header_right_wrapper">
                <div class="search-form">
                    <form action="food-and-drug-administration-0.html" method="post" id="search-block-form" accept-charset="UTF-8"><div><div class="container-inline">
  <div class = "input-group"><div class="form-type-textfield form-item-search-block-form form-item form-group">
  <label class="element-invisible" for="edit-search-block-form--2">Search </label>
 <input title="Enter the terms you wish to search for." placeholder="Search Site..." class="form-control form-control form-text" type="text" id="edit-search-block-form--2" name="search_block_form" value="" size="15" maxlength="128" />
</div>
<div class="form-actions form-wrapper" id="edit-actions--2"><input class="btn btn-primary btn-icon form-submit" type="image" id="edit-submit" name="submit" value="Search" src="../../sites/all/themes/stability/stability_aspe/images/search-white2.png" alt="Search" title="Search" /></div></div><input type="hidden" name="form_build_id" value="form-tcxjgg4Cmbb6Tih14rkG1HGtQy1rZZEUq9SkSTAqAqY" />
<input type="hidden" name="form_id" value="search_block_form" />
</div>
</div></form>                </div>
                <button type="button" class="navbar-toggle" value="Menu">
                    <i class="fa fa-bars"></i>Menu
                </button>
            </div>

        </div>
    </div>

    <!-- Navigation -->
    <nav id="nav" class="nav-main">
        <div class="container">
          <ul data-breakpoint="767" class="flexnav">
                <li class="first expanded"><a href="../../basic-search/about.html" title="">About</a><ul><li class="first leaf"><a href="../../node/41366.html" title="">Mission</a></li>
<li class="leaf"><a href="../../key-staff.html" title="">Leadership</a></li>
<li class="leaf"><a href="https://www.usajobs.gov/" title="">Careers</a></li>
<li class="expanded"><a href="../../node/83081.html" title="linkTo">Coordination</a><ul><li class="first leaf"><a href="../../node/94561.html" title="">Evaluation &amp; Evidence</a></li>
<li class="leaf"><a href="../../node/83126.html">National Alzheimer&#039;s Project Act</a></li>
<li class="leaf"><a href="../../hhs-data-council.html">HHS Data Council</a></li>
<li class="last leaf"><a href="../../node/83076.html" title="National Council on Vital and Health Statistics">National Council on Vital and Health Statistics</a></li>
</ul></li>
<li class="expanded"><a href="../../basic-search/divisions.html" title="">Offices</a><ul><li class="first leaf"><a href="../../daltcp/home.htm">Disability, Aging, and Long-Term Care Policy</a></li>
<li class="leaf"><a href="../../node/57001.html">Health Policy</a></li>
<li class="leaf"><a href="../../hsp/index.shtml.html">Human Services Policy</a></li>
<li class="last leaf"><a href="../../node/57011.html">Science and Data Policy</a></li>
</ul></li>
<li class="leaf"><a href="../../node/83096.html" title="Strategic Planning">Strategic Planning</a></li>
<li class="last leaf"><a href="../../node/83911.html" title="">Contact ASPE</a></li>
</ul></li>
<li class="expanded"><a href="../../basic-search/topics.html" title="">Topics</a><ul><li class="first leaf"><a href="../../health/reports/2012/ACA-Research/index.cfm.html">Affordable Care Act Research</a></li>
<li class="leaf"><a href="../../node/101296.html">Alzheimer&#039;s / Dementia</a></li>
<li class="leaf"><a href="../../node/105551.html">Early Childhood</a></li>
<li class="leaf"><a href="../../node/103281.html">Incarceration &amp; Reentry</a></li>
<li class="leaf"><a href="../../node/83056.html" title="Opioids">Opioids</a></li>
<li class="leaf"><a href="../../node/83296.html">Patient-Centered Outcomes Research Trust Fund (PCORTF)</a></li>
<li class="expanded"><a href="../../basic-search/poverty.html" title="">Poverty</a><ul><li class="first leaf"><a href="../../node/107166.html">Poverty Guidelines</a></li>
<li class="last leaf"><a href="../../node/107171.html">Poverty Analysis</a></li>
</ul></li>
<li class="leaf"><a href="../../node/164501.html">Teen Pregnancy Prevention</a></li>
<li class="leaf"><a href="../../node/100556.html">Homelessness</a></li>
<li class="last leaf"><a href="../../node/117441.html">MACRA</a></li>
</ul></li>
<li class="leaf"><a href="../../reports.html" title="">Publications</a></li>
<li class="last expanded"><a href="../../basic-search/datasets.html" title="">Data and Tools</a><ul><li class="first last leaf"><a href="../../pic/index.cfm.html" title="">Evaluation Database</a></li>
</ul></li>
            </ul>
        </div>
    </nav>
    <!-- Navigation / End -->
</header>  <div class="main" role="main">
    <!--PAGEWATCH CODE="USHHS_458"-->
    <section class="page-heading">
  <div class="container">
    <div class="row">

        <div class="col-md-6">
                <h1>
                                  Performance Improvement 1998.
                    
          Food and Drug Administration        </h1>
                                 <p class="author">
                                                 <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="1998-02-01T00:00:00-05:00">02/01/1998</span>               
                           </p>


                  </div>


        <div class="col-md-6">
           <ul class="breadcrumb"><li class="first"><a href="../../images/exit_disclaimer.jpg.html" title="Home">Home</a></li>
<li><a href="../performance-improvement-1998.1.html" title="Performance Improvement 1998">Performance Improvement 1998</a></li>
<li><a href="chapter-iii-hhs-agency-evaluation-activities.html" title="Chapter III. HHS Agency Evaluation Activities">Chapter III. HHS Agency Evalua...</a></li>
<li class="last">Food and Drug Administration</li>
</ul>        </div>


    </div>
  </div>
</section>
    
      <div  class="nd-region nd-region-filter">
  
       

    
      <div  id="Filter" class="row">     

        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
      </div>

    
    
      </div>
    


      <div  class="nd-region nd-region-similar-content">
  
       

    
      <div  id="Similar-Content" class="row">     

        
                  
        
                                    <div  id="top" class="">
                          
                              <div id="block-views-2100ccfdd214bdbcf634d7e4832c265b" class="widget block block-views solr-similar-content" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Similar</span> content</h3>
		</div>
    
  <div class="view view-similar-content-solr view-id-similar_content_solr view-display-id-block_solr_similar_content view-dom-id-dfb0ea9b6ebf50d4c6f6b5f965f07796">
        
  
  
      
    
    <span class="field-content"><a href="https://aspe.hhs.gov/policy-information-center-highlights-vol-8-no-1">Policy Information Center Highlights: Vol. 8, No. 1</a></span>    
    <span class="field-content"><a href="../../fda-â%2580%2594-menthol-cigarette-background-paper-response-rfr.html">FDA â€” Menthol Cigarette Background Paper: Response to RFR</a></span>    
    <span class="field-content"><a href="../../sp/reports/2012/frontofpackagenutritionlabelingfinal/longdesc.shtml.html">Evaluation Planning and Tools for Front of Package Nutrition  Labeling.   Final Report</a></span>    
    <span class="field-content"><a href="https://aspe.hhs.gov/fda-%E2%80%94-defibrillator-training-link-request-correction-rfc">FDA â€” Defibrillator Training Link: Request for Correction (RFC)</a></span>    
    <span class="field-content"><a href="https://aspe.hhs.gov/fda-%E2%80%94-menthol-cigarette-background-paper-interim-response-may-1-2012">FDA â€” Menthol Cigarette Background Paper: Interim Response, May 1, 2012</a></span>  
  
  
  
  
  
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
      </div>

    
    
      </div>
    


      <div  class="nd-region">
  
       

          <div class = "container">
    
      <div  class="row" id="Content">     

        
                  
        
                  
        
                  
        
                                    <div  class="col-md-12 " id="content">
                          
                              <div id="block-aspe-aspe-addthis" class="widget block block-aspe" >
  
      
  <div class="clearfix">
  <ul class="addthis_sharing_toolbox node-share__links" data-url="https://aspe.hhs.gov/report/performance-improvement-1998/food-and-drug-administration-0" data-title="Food and Drug Administration">
    <li><a class="addthis_button_print"><img src="../../sites/all/themes/stability/stability_aspe/images/print-white.png" alt="print" /></a></li>
    <li><a class="addthis_button_email"><img src="../../sites/all/themes/stability/stability_aspe/images/mail-white.png" alt="email" /></a></li>
    <li><a class="addthis_button_twitter"><img src="../../sites/all/themes/stability/stability_aspe/images/tw.png" alt="twitter" /></a></li>
<!--    <li><a class="addthis_button_facebook">--><!--</a></li>-->
    <li><a class="addthis_button_compact"><img src="../../sites/all/themes/stability/stability_aspe/images/plus-white.png" alt="compact" /></a></li>
  </ul>
</div>

  </div> <!-- /.block -->

                
    
  
  <div class="content clearfix node-book ">
    <p><b>MISSION: To protect and 		promote public health through food, drug, medical device, and cosmetic 		regulation.</b> </p>
<p><b><i>Evaluation 		Program</i></b> </p>
<p>The evaluation program of 		the Food and Drug Administration (FDA) continues to be aligned with the 		Agency's policy, its program and strategic planning initiatives, and the goals 		of the Government Performance and Results Act (GPRA). Since GPRA and the 		reorientation of all government managers toward performance management, the 		responsibility for program evaluation has shifted from traditional specialized 		staff offices and contractor studies to managers of all FDA programs. In 		addition, FDA managers are identifying further opportunities to involve their 		customers in the design and testing of alternative ways of doing business. Both 		performance-based goals and customer participation also impact FDA's response 		to the needs of small businesses and enhance the participation and performance 		of small businesses. </p>
<p>One element of FDA's 		strategic framework is called external leveraging. The goal here is to augment 		the ability of external stakeholders to manage FDA-regulated risk. FDA's 		evaluation program illustrates the implementation of this goal with a number of 		studies under way or completed during FY 1997 that illustrate the strategies 		that FDA is using to accomplish this goal. One strategy is the fostering of an 		industry quality assurance program, where FDA will establish protocols to guide 		firms, certify their approaches, and audit industry practices. A current 		example of this quality assurance is the Mammography Quality and Standards Act 		(MQSA), which monitors the administration of mammography practices. The 		following reports are based on evaluations of mammography activities: the 		<i><b>Mammography Quality Standards Act: Second Annual Government Entity 		Declaration Program Audit,</b> </i>and the<i> <b>Economic Impact Analysis of 		Regulations Under the Mammography Quality Standards Act of 1992</b></i><b>.</b> 		In addition, the Center for Safety and Applied Nutrition (CFSAN) has 		implemented the<i> <b>Survey of Current Hazard Assessment Quality Control 		Points (HAACP) Practices of the Food Industry</b></i><b>.</b> While excluding 		seafood, this survey originated as a result of the Seafood HAACP Program, 		another FDA-fostered quality assurance program. </p>
<p>Other CFSAN evaluations, 		both completed and in progress, are clearly in line with FDA's objective of 		communicating risk associated with FDA-regulated products. These studies are 		directly linked to the President's National Food Safety Initiative, which will 		involve a collaboration between FDA, the U.S. Department of Agriculture (USDA), 		the Environmental Protection Agency (EPA), and the Centers for Disease Control 		and Prevention (CDC) in order to assure safety and quality of our food supply. 		Special emphasis will be placed on microbial hazards, which account for 90 		percent of the confirmed food-borne outbreaks, 6.5 to 33 million illnesses, and 		9,000 deaths in the U.S. annually. Since food-borne chemical hazards often 		present chronic rather than acute health threats, specific estimates of their 		impact on health and the economy are not readily available. Finally, data 		collected from the FDA's <b><i>Safe Alert Survey</i></b> will demonstrate how 		well the Agency is communicating risk associated with medical devices to the 		medical community. </p>
<p><b><i>Summary of Fiscal 		Year 1997 Evaluations</i></b> </p>
<p>Prescription Drug User Fee 		Act </p>
<p>The Prescription Drug User 		Fee Act (PDUFA) has demonstrated that the Agency and industry, by combining 		their resources and working together, can achieve the levels of performance the 		American people deserve. The fifth and final report completed in November 1997 		demonstrates that the successes reported in FY 1996 have been confirmed and 		surpassed. PDUFA has resulted in more and better applications filed which can 		be accepted immediately, reviewed, and approved more quickly (6079.2). Nearly 		all applications now go directly into the review process, with "applications 		refused" approaching the vanishing point. There are substantially more 		approvals on first review, which demonstrates that submission quality is a key 		factor in achieving timely approvals. Another indication of improved submission 		quality is the dramatic increase in the percentage of submissions that are 		ultimately approved faster. By working to meet the PDUFA's stringent review 		goals, new products are getting on the market at an unprecedented pace without 		compromising safety. </p>
<p><b><i>Product Review 		Performance Report</i></b> </p>
<p>In FY 1997, FDA completed 		its first annual report analyzing performance in reviewing applications for 		human drugs, biological products, medical devices, food and color additives, 		and veterinary drugs (6731). Responding to legislation (such as PDUFA) as well 		as to requirements under the Federal Food, Drug, and Cosmetic Act, FDA has 		developed clear performance goals for reviewing new product applications. 		Setting these goals has provided a valuable management tool for identifying 		performance expectations, assessing achievements, and meeting the requirements 		of GPRA. The report finds that (1) for most categories of products, FDA 		performance has improved since FY 1993; (2) the greatest improvements in 		performance have occurred for product reviews covered by PDUFA; (3) significant 		progress has been made in reviewing applications for medical devices; and (4) 		on-time performance for reviews of non-PDUFA applications should be 		improved. </p>
<p><b><i>Assessment of the 		Mammography Quality Standards Act of 1992 (MQSA)</i></b> </p>
<p>Under this statute, FDA is 		charged with ensuring that accessibility to quality mammography services is 		maintained for all facilities performing mammographies. This program is FDA's 		second major user-fee, performance-oriented, GPRA-style initiative. During FY 		1997, Eastern Research Group, Inc. completed an economic analysis of FDA's 		final rule under MQSA working under contract to the Office of Planning and 		Evaluation (OPE), Economics Staff. The purpose of the cost-benefit analysis was 		to predict the impact of the proposed standards on the costs of providing 		mammography. The results of their analysis are presented in the report 		entitled, <i><b>Economic Impact Analysis of Regulations Under the Mammography 		Quality Standards Act of 1992</b> </i>(6080). The results of this analysis will 		be used by FDA's managers to develop a performance-oriented regulatory policy 		that will be coordinated with existing customers. OPE's Economics Staff 		developed a model for estimating health outcomes to a patient population at 		various levels of mammography quality. </p>
<p><b><i>Quality Standards 		Act: Second Annual Government Entity Declaration Program Audit and the Economic 		Impact Analysis of Regulations Under the Mammography Quality Standards Act of 		1992</i></b> </p>
<p>FDA's Division of 		Mammography Quality and Radiation Programs requested an audit of the MQSA 		Government Entity (GE) Declaration Program (6730). The audit was undertaken by 		the Division of Planning, Analysis, and Finance. The goals of the audit were to 		notify facilities that they will be held accountable for their 		self-certification of fee exemption and to determine the rate of compliance 		with the program. Based on the results, the auditors concluded that the GE 		Declaration Program appears to be quite effective. Several recommendations were 		made based on the findings of the audit. First, the results should be published 		to allow the impact of the audit to reach most of the facilities. This would 		discourage any future misrepresentations and demonstrate that FDA will exercise 		its authority. Second, the sample size of future audits should be smaller and 		should contain a larger portion of those facilities claiming fee exemption 		based solely on funding from the CDC. Finally, the MQSA contractor should 		continue to examine each GE Declaration form to ensure that it identifies the 		body operating the facility. </p>
<p><b><i>Evaluation of Device 		Performance in the Determination of Substantial 		Equivalence</i></b> </p>
<p>Many diagnostic medical 		devices that reach the market are based on diagnostic agreement with some 		device already on the market that targets the same attribute. Agreement is 		often assessed by side-by-side testing of the same subjects or specimens, even 		if the true disease status is unknown. If each new test is compared with the 		most recent predicate, what would be the effect on device performance over 		time? Would it deteriorate, remain the same, or improve? FDA produced an 		analysis that addressed these questions using statistical measures of 		sensitivity, specificity, and predictive values (6734). When a new test was 		found to be equivalent to the current predicate, it became the new predicate. 		After 50 new predicates were found, a forecast procedure was applied to the 		sequence of 50 performance parameters in order to evaluate the long-term 		trend. </p>
<p><b><i>Center for Food 		Safety and Applied Nutrition (CFSAN) Evaluation</i></b> </p>
<p>During FY 1997, three 		evaluations relating to food issues were completed by the Economics Branch in 		CFSAN's Division of Market Studies. The first, <b><i>Preliminary Investigation 		into the Morbidity and Mortality Associated with the Consumption of Fruit and 		Vegetable Juices</i></b> (6858), assessed the population risk from the 		consumption of fruit and vegetable juices. The main risks studied were 		microbial pathogens. Two studies evaluated regulation of the seafood industry: 		<b><i>Cost of Restrictions on Gulf Oyster Harvesting for Control of</i> 		Vibrio<i> </i>vulnificus<i>-Caused Disease</i></b><i> </i>(6856), an economic 		impact analysis of alternative remedies for controlling <b><i>Vibrio</i> 		<i>vulnificus</i></b>-related illnesses in the Gulf States oyster industry, and 		<b><i>Health Transfers: An Application of Health-Health Analysis to Assess Food 		Safety Regulation </i></b>(6857), an evaluation tool based on the first study's 		methodology that can be used to measure economic versus health costs of public 		health decisions. </p>
<p><b><i>Evaluations in 		Progress</i></b> </p>
<p>FDA currently has a broad 		range of evaluations in progress which, as in previous years, are based upon 		the two driving forces relating to GPRA goals: performance management and 		customer participation (with particular focus on small businesses). The 		following are examples of FDA evaluations in progress during FY 		1997. </p>
<p>Although PDUFA ends in FY 		1997, FDA and the pharmaceutical and biological prescription drug industry have 		negotiated re-enactment beyond FY 1997. Reauthorization of the collection of 		user fees under the Food and Drug Administration Modernization Act (enacted in 		November 1997) will continue to enhance the review process of new human drugs 		and biological products (6079.3). The PDUFA program serves as a model for 		reinventing government, with the Congress, FDA, the industry, and consumer 		groups working together to provide the necessary resources, set performance 		goals, and hold the Agency accountable. Revenues generated from the fees paid 		by the pharmaceutical and biological prescription drug industries will continue 		to be dedicated to improving and expediting the prescription and application 		review and approval process. The legislation reauthorizing PDUFA for FY 1998 		was critical in ensuring uninterrupted service to U.S. customers. 		</p>
<p><b><i>Evaluation of 		Influenza Virus Vaccines in High-Risk Patient Categories</i></b> (4355) is 		intended to ensure public health by investigating the reactogenicity and 		immunogenicity of influenza virus vaccines. The information will be critical to 		making accurate recommendations for the selection of new strains of the 		influenza virus vaccine to be used in the United States. </p>
<p><b><i>Nationwide Evaluation 		of X-Ray Trends (NEXT)</i></b> (4984) is a collaborative program conducted 		jointly between FDA and State radiation control agencies. The study estimates 		the radiation dosage from diagnostic x-ray examinations using data collected 		from previous NEXT surveys of different types of x-ray examinations. The data 		are used by public health and professional organizations in setting 		policy. </p>
<p><b><i>Food Labeling and 		Package Survey (FLAPS)</i></b> (5711) was implemented by the FDA in 1977 to 		produce a data base containing label and package information obtained from a 		sample of food products from the processed packaged food industry. FLAPS data 		enable FDA personnel to keep abreast of market responses to food labeling rules 		via changes in product package labels. </p>
<p><b><i>FDA Penalty Reduction 		Program for Small Businesses</i></b> (6461) reviews pre-existing and revised 		policies related to monetary penalties for noncompliance with FDA regulations, 		evaluates the scope of small businesses that qualified (or failed to qualify) 		for the program, and assesses the total amount of penalty reductions or 		waivers. The Small Business Regulatory Enforcement Fairness Act (SBREFA) 		required FDA to create a program or policy that specifies the circumstances 		under which the Agency may reduce or waive the penalties levied against small 		business entities for noncompliance. The final report for this project is 		anticipated in March 1998. </p>
<p><b><i>FDA Inquiries 		Assistance Program for Small Businesses</i></b> (6462) is FDA's response to the 		SBREFA requirement to establish a program to respond to inquiries and to help 		small businesses and other small entities apply FDA rules. The report on this 		project is anticipated in March 1998. </p>
<p>During FY 1998, FDA will 		continue to implement the requirements of the <i><b>Mammography Quality 		Standards Act of 1992 (MQSA)</b> </i>(6080.1). FDA requested an increase in 		MQSA authorized inspection fees over the FY 1997 level. Continuing 		implementation of the MQSA requirements is essential to ensure that women 		receive quality mammography from facilities that maintain a high standard of 		safety and accuracy. The primary emphasis of this program for FY 1998 will be 		to continue to ensure that all facilities meet the quality standards and that 		deficiencies previously identified through annual inspections are corrected. In 		FY 1998, Federal and State personnel will continue to conduct annual 		inspections of 10,000 facilities and certifications of 6,000 facilities, and to 		provide training for new inspectors. The fees will be used to pay for the costs 		of the inspections. </p>
<p><b><i>Review of Therapeutic 		Agents as an Antimicrobial Adjunct in Treatment of Sepsis</i></b> (6736) is a 		technique used in the drug approval process. No therapeutic agent has yet been 		identified that shows either a clinical benefit or an alternative that is 		superior to standard care. FDA faces many challenges in designing clinical 		trials that demonstrate efficacy. These are due to the heterogeneity of patient 		populations, poor understanding of the pathophysiology of acute sepsis, and no 		uniformly-accepted standard of care in these international trials. Intensive 		efforts have been undertaken by FDA to propose the optimal trial design and 		prospective analysis plans. This analysis of failed sepsis trials is being 		conducted by FDA to achieve better clinical trial results for the evaluation of 		adjunctive sepsis therapy in the future. </p>
<p>The <b><i>Real-Time PMA 		Supplement Program Evaluation</i></b> (6732), implemented by the Office of 		Device Evaluation (ODE), has evolved as a result of the Medical Device Review 		of the Premarket Approval (PMA) Applications program. FDA has reduced review 		times and backlogs for medical device applications. But, in order to achieve 		mandated goals, continued improvement is needed. FDA requested an increase in 		funds for FY 1998 in order to improve the quality and timeliness of its review 		process for Class III PMA applications and PMA supplements. These applications 		involve the highest-risk devices that require full clinical investigations of 		safety and efficacy. An increase in funding will facilitate FDA in allocating 		more resources to the PMA process without sacrificing performance gains made in 		the 510(k) program. It is projected that FY 1998 will be the first year of this 		enhancement effort, and FDA expects a 15 percent increase in PMA workload 		during FY 1997 and FY 1998 due to requests for reclassifications and 		submissions of required preamendment PMAs. Given these additional resources, 		FDA will attempt to limit the increase in pending PMAs at the end of FY 1998 to 		5 percent. FDA has defined specific review performance goals for Class III 		applications that should be achieved by the end of FY 1998 with the additional 		resources. </p>
<p>The<i> <b>Safe Alert 		Satisfaction Survey</b></i> (6733) will determine the impact of the safety 		alert and public health advisory on the behavior and knowledge of the public. 		The collection of these data is an important step in determining how 		effectively FDA is communicating risk to the public. </p>
<p><b><i>Survey of Current 		Hazard Analysis and Critical Control Point (HACCP) Practices of the Food 		Industry</i></b> (6866) is a two-part survey that will yield information that 		will be used to estimate the HACCP-related practices of the food industry 		(except seafood, meat, and poultry), and a model that will be used to estimate 		the marginal costs of firms to comply with HACCP. </p>
<p><b><i>Economic 		Characterization of the Dietary Supplement Industry</i></b> (6867) will provide 		a detailed analysis of the dietary supplement industry, including a description 		of the types of firms producing and marketing dietary supplements, and will 		create a relational data base that will link firms to products. 		</p>
<p><b><i>Estimating the 		Benefits of Various Kinds of Food Standards</i></b> (6865) will categorize food 		standards by type of food and function and to estimate consumers' valuations of 		those functions. </p>
<p><b><i>Harmonizing 		Nutritional Goals and Food Processing</i></b> (6864) is a paper to be given at 		the "Towards Convergence on the Dietary Guidelines, Research and Policy Needs 		in the Nutrition, Health, and Agricultural Sectors" conference on April 30, 		1998. </p>
<p>The<i> <b>Impact of Tobacco 		Initiative on Youth</b></i><b> </b>(6890) is a project in which Office of 		Planning and Evaluation staff are currently designing a sample questionnaire to 		facilitate data collection on tobacco use. The survey responder will determine 		whether the tobacco initiative has had any positive impact on the propensity of 		youth to use these products. In August 1996, President Clinton approved FDA's 		final rule for regulating tobacco products. The President's Tobacco Initiative 		demonstrates a collaborative effort to thwart major public health risk with the 		objective of decreasing tobacco use over the next 7 years. FDA is working with 		the States to conduct unannounced compliance checks of retail establishments 		that sell tobacco products. FDA will rely on Federal and State agencies to 		monitor retailer compliance with the new regulations and track the degree of 		success in decreasing tobacco use by youth. </p>
<p><b></b></p>
<div class="group-tags"><div class="field-label">Tags:&nbsp;</div><a href="https://aspe.hhs.gov/terms/program-performance-evaluation-reports-1995-2002">Program Performance Evaluation Reports, 1995-2002</a></div>  </div>

      <footer>
          </footer>
  
    <div id="block-webform-client-block-158521" class="widget block block-webform" >
  
      
  <div id="webform-ajax-wrapper-158521"><form class="webform-client-form webform-client-form-158521" action="food-and-drug-administration-0.html" method="post" id="webform-client-form-158521" accept-charset="UTF-8"><div><div class="webform-progressbar">
  

  
  </div>
<div  class="form-item webform-component webform-component-radios webform-component--was-this-page-helpful">
  <label for="edit-submitted-was-this-page-helpful">Was this page helpful? <span class="form-required" title="This field is required.">*</span></label>
 <div id="edit-submitted-was-this-page-helpful" class="form-radios"><div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-1" name="submitted[was_this_page_helpful]" value="1" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-1">Yes </label>

</div>
<div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-2" name="submitted[was_this_page_helpful]" value="0" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-2">No </label>

</div>
</div>
</div>
<input type="hidden" name="details[sid]" />
<input type="hidden" name="details[page_num]" value="1" />
<input type="hidden" name="details[page_count]" value="4" />
<input type="hidden" name="details[finished]" value="0" />
<input type="hidden" name="form_build_id" value="form-k8KLlcr7fWqa6jQssjiHCN19_UCF5HlJAQYQBGJgluo" />
<input type="hidden" name="form_id" value="webform_client_form_158521" />
<input type="hidden" name="webform_ajax_wrapper_id" value="webform-ajax-wrapper-158521" />
<div class="form-actions"><input class="webform-next button-primary btn btn-default form-submit" type="submit" id="edit-webform-ajax-next-158521" name="op" value="Next &gt;" /></div>
<div class="is-useful-disclaimer"> <a href="https://aspe.hhs.gov/%23" class="" title="Survey Disclaimer" data-toggle="modal" data-target="#disclamerModal">Form Approved OMB# 0990-0379 Exp. Date 8/31/2017</a></div>
<div class="modal fade" id="disclamerModal" tabindex="-1" role="dialog" aria-labelledby="disclamerModalLabel">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
        <h2 class="modal-title" id="disclamerModalLabel">Survey Disclaimer</h2>
      </div>
      <div class="modal-body">
         According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0379. The time required to complete this information collection is estimated to average 5 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.      </div>
    </div>
  </div>
</div></div></form></div>
  </div> <!-- /.block -->
<meta  itemscope="" itemid="https://aspe.hhs.gov/report/performance-improvement-1998/food-and-drug-administration-0" itemref="md1 md3" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/program-performance-evaluation-reports-1995-2002" id="md3" itemref="md2" />              
                          </div>
                              
        
                  
        
                  
        
                  
        
                  
        
      </div>

          </div>
    
    
      </div>
    


      <footer  class="nd-region">
  
       

          <div class = "container">
    
      <div  class="row" id="Footer">     

        
                  
        
                  
        
                  
        
                  
        
                                    <div  id="footer_sitemap-footer_sitemap" class="col-sm-6 col-md-6 col-lg-4 ">
                          
                              <div id="block-footer-sitemap-footer-sitemap" class="widget block block-footer-sitemap" >
  
      
  <div id="footer-sitemap" class="clearfix">
  <div class="fs-block-content"><div class="menu-footer-utility"><ul class="footer_links_menu-footer-utility total-items-2 parent-items-0 single-items-0"><li class="menu-5021 depth-1 total-children-8 parent-children-0 single-children-8  first"><a href="../../images/exit_disclaimer.jpg.html" title="look at ASPE Home" class="fs-root-link">ASPE Home</a><ul class="footer_links_menu-footer-utility total-items-8 parent-items-0 single-items-0"><li class="menu-5026 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/" title="look at HHS Home">HHS Home</a></li>
<li class="menu-66281 depth-1 fs-no-children"><a href="http://www.usa.gov/" title="look at USA.gov">USA.gov</a></li>
<li class="menu-66316 depth-1 fs-no-children"><a href="https://oig.hhs.gov/" title="look at Office of the Inspector General">Office of the Inspector General</a></li>
<li class="menu-66321 depth-1 fs-no-children"><a href="http://www.whitehouse.gov" title="look at The White House">The White House</a></li>
<li class="menu-5046 depth-1 fs-no-children"><a href="http://www.hhs.gov/Accessibility.html" title="look at Accessibility">Accessibility</a></li>
<li class="menu-66326 depth-1 fs-no-children"><a href="http://www.hhs.gov/about/budget/index.html" title="look at Budget/Performance">Budget/Performance</a></li>
<li class="menu-2551 depth-1 fs-no-children"><a href="http://www.hhs.gov/Privacy.html" title="look at Privacy Policy">Privacy Policy</a></li>
<li class="menu-197776 depth-1 fs-no-children  last"><a href="https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html" title="Nondiscrimination Notice">Nondiscrimination Notice</a></li>
</ul></li>
<li class="menu-5051 depth-1 total-children-4 parent-children-0 single-children-4  last"><a href="http://www.hhs.gov/foia/" title="look at FOIA" class="fs-root-link">FOIA</a><ul class="footer_links_menu-footer-utility total-items-4 parent-items-0 single-items-0"><li class="menu-5056 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/open/recordsandreports/plainwritingact/index.html" title="look at Plain Writing Act">Plain Writing Act</a></li>
<li class="menu-5061 depth-1 fs-no-children"><a href="http://www.hhs.gov/asa/eeo/no_fear_bullet_3.html" title="look at No Fear Act">No Fear Act</a></li>
<li class="menu-5066 depth-1 fs-no-children"><a href="http://www.hhs.gov/Disclaimer.html" title="look at Disclaimers">Disclaimers</a></li>
<li class="menu-2546 depth-1 fs-no-children  last"><a href="http://www.hhs.gov/plugins.html" title="look at Viewers &amp; Players">Viewers &amp; Players</a></li>
</ul></li>
</ul></div>
</div>
</div>

  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-5 " id="stability_cms-contact_us">
                          
                              <div id="block-stability-cms-contact-us" class="widget block block-stability-cms" >
  
      
  <div class="contacts-widget widget widget__footer">
	<div class="widget-content">
		<ul class="contacts-info-list">
      			<li>
<!--				<i class="fa fa-map-marker">Address</i>-->
                <div class="info-icons">
                    <img  alt="map" class= 'map-icons' src="../../sites/all/themes/stability/stability_aspe/images/map.png"/>
                </div>
                <div class="info-item">
					Assistant Secretary for Planning and Evaluation, Room 415F<br />
U.S. Department of Health and Human Services<br />
200 Independence Avenue, SW<br />
Washington, D.C. 20201				</div>
			</li>
            			<li>
<!--				<i class="fa fa-phone">phone</i>-->
                <div class="info-icons">
                    <img alt="phone" src="../../sites/all/themes/stability/stability_aspe/images/phone.png"/>
                </div>
				<div class="info-item">
					+1 202.690.7858				</div>
			</li>
            			<li>
<!--				<i class="fa fa-envelope">email</i>-->
                <div class="info-icons">
                    <img alt="mail" src="../../sites/all/themes/stability/stability_aspe/images/mail-white.png"/>
                </div>
				<span class="info-item">
					<a href="mailto:osaspeinfo@hhs.gov">osaspeinfo@hhs.gov</a>
				</span>
			</li>
      			                					</ul>
	</div>
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-3 " id="footer">
                          
                              <div id="block-block-36" class="widget block block-block" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Sign-up</span> for Email Updates</h3>
		</div>
    
  <div class="email_updates">
<button class="btn btn-default" name="subscribe-button" type="submit" value="subscribe">subscribe</button>
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-12 " id="menu-menu-footer-language-menu">
                          
                              <div id="block-menu-menu-footer-language-menu" class="widget block block-menu" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Language</span> Assistance Available</h3>
		</div>
    
  <ul class="menu"><li class="first expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#spanish" title="EspaÃ±ol">EspaÃ±ol</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#chinese" title="ç¹é«”ä¸­æ–‡">ç¹é«”ä¸­æ–‡</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#vietnamese" title="Tiáº¿ng Viá»‡t">Tiáº¿ng Viá»‡t</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#korean" title="í•œêµ­ì–´">í•œêµ­ì–´</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#tagalog" title="Tagalog">Tagalog</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#russian" title="Ð ÑƒÑÑÐºÐ¸Ð¹">Ð ÑƒÑÑÐºÐ¸Ð¹</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#arabic" title="Ø§Ù„Ø¹Ø±Ø¨ÙŠØ©">Ø§Ù„Ø¹Ø±Ø¨ÙŠØ©</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#creole" title="KreyÃ²l Ayisyen">KreyÃ²l Ayisyen</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#french" title="FranÃ§ais">FranÃ§ais</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#polish" title="Polski">Polski</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#portuguese" title="PortuguÃªs">PortuguÃªs</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#italian" title="Italiano">Italiano</a></li>
</ul></li>
<li class="last expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#german" title="Deutsch">Deutsch</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#japanese" title="æ—¥æœ¬èªž">æ—¥æœ¬èªž</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#farsi" title="ÙØ§Ø±Ø³ÛŒ">ÙØ§Ø±Ø³ÛŒ</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#english" title="English">English</a></li>
</ul></li>
</ul>
  </div> <!-- /.block -->
              
                          </div>
                              
        
      </div>

          </div>
    
    
      </footer>
    

    <!--/PAGEWATCH-->
    <div class="footer-copyright">
      <div class="container">
        <div class="row">
          <div class="col-sm-6 col-md-4">
                        </div>
          <div class="col-sm-6 col-md-8">
            <div class="social-links-wrapper">
              <span class="social-links-txt">Connect with us</span>
              <ul class="social-links social-links__dark">
                                                  <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="../../sites/all/themes/stability/stability_aspe/images/tw-grey.png"/></a></li>
                                <!--                --><!--                  <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin-grey.png"/></a></li>-->
<!--                -->
                                                              </ul>
            </div>
          </div>
        </div>
      </div>
    </div>

  </div>
</div>  <script type="text/javascript" src="../../sites/default/files/advagg_js/js__VWRymaMz6HfrhnrcJNGcDiSvLVrvhaXvBa7nrBYy8gc__jntPwP3D6myJZH1jW19fXrk5cYMHGRL8NQION22VSEA__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5486d15a696bff0c"></script>
<script type="text/javascript" src="../../sites/default/files/advagg_js/js__g6mKbcakHxQkz4ZHYaxdO_xqONINvRMgsHh1zAK-fr0__ATHtEmHaeZ0jidpGU22EkhmPDBSgjD8z0bVDQMI-BIY__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../../sites/default/files/advagg_js/js__KUp4PrfOt9BSXUVl8Ctb3dhCMBe4MNVMeb4Gyorx8yY__7g4BeXscCIZAfuu1vxsCj2RIemg-eEK0QpChP9LDmFQ__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../../sites/default/files/advagg_js/js__-lTibmScdz72f0-5WA9kxuPp-TZJEfyLCI6M2oC8I7o__WokrfyLOTIIjCC2mi9PpCwBq3hzxExmsz_JSnp4-OsM__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../../sites/default/files/advagg_js/js__vQiLul2UcfC4nBAR09mhYVBYzRmiNDm2dj3GgSubV38__w84oZe-ZODKe7XnnlbrjV4IWHISOy4PioFEMVgx9hZo__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../../sites/default/files/advagg_js/js__QJw3g0kOdwsv4twSZLP931zBzsHy50VEHpEN_znIitQ__A6QOuWXElDipBM2iChbWhjAAt3KlUwZ-jODoxdpbwiw__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"stability_aspe","theme_token":"-15-0qNT8NUY6EY8oZNMMR8ctH97kzKDojBycZoLCC4","jquery_version":"1.10","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.messages.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/footable.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/aspe_nodes.admin.css":1,"sites\/all\/modules\/custom\/aspe_views\/theme\/css\/aspe_views.admin.css":1,"sites\/all\/modules\/forked\/book\/book.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_api\/date.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/footer_sitemap\/footer_sitemap.css":1,"modules\/node\/node.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/extlink.css":1,"profiles\/openpublic\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/media\/modules\/media_wysiwyg\/css\/media_wysiwyg.base.css":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.css":1,"profiles\/openpublic\/modules\/contrib\/ctools\/css\/ctools.css":1,"profiles\/openpublic\/modules\/contrib\/panels\/css\/panels.css":1,"profiles\/openpublic\/modules\/contrib\/webform\/css\/webform.css":1,"sites\/default\/files\/css\/follow.css":1,"sites\/all\/themes\/stability\/css\/bootstrap.min.css":1,"sites\/all\/themes\/stability\/css\/fonts\/font-awesome\/css\/font-awesome.min.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.theme.css":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/magnific-popup.css":1,"sites\/all\/themes\/stability\/vendor\/mediaelement\/mediaelementplayer.css":1,"sites\/all\/themes\/stability\/css\/theme.css":1,"sites\/all\/themes\/stability\/css\/theme-elements.css":1,"sites\/all\/themes\/stability\/css\/animate.min.css":1,"sites\/all\/themes\/stability\/css\/skins\/red.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/slideshow.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/font-main.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/styleless.less":1,"sites\/all\/themes\/stability\/css\/skins\/blue.css":1},"js":{"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.10\/jquery.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/misc\/jquery.form.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/aspe\/theme\/js\/aspe.login-confirm.js":1,"sites\/all\/modules\/custom\/aspe_report\/modules\/aspe_databooks\/js\/aspe_databooks.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.highcharts.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.js":1,"sites\/all\/modules\/contrib\/extlink\/extlink.js":1,"sites\/all\/libraries\/datatables\/dataTables.min.js":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.min.js":1,"sites\/all\/libraries\/highcharts\/highcharts.js":1,"sites\/all\/libraries\/highcharts\/highcharts.exporting.js":1,"sites\/all\/libraries\/highcharts\/highcharts.map.js":1,"sites\/all\/libraries\/highcharts\/highcharts.us-all.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.footable.js":1,"http:\/\/s7.addthis.com\/js\/300\/addthis_widget.js#pubid=ra-5486d15a696bff0c":1,"misc\/progress.js":1,"profiles\/openpublic\/modules\/contrib\/webform\/js\/webform.js":1,"sites\/all\/modules\/custom\/aspe_book\/theme\/js\/async.js":1,"sites\/all\/modules\/custom\/aspe_book\/theme\/js\/aspe_book.jquery_ajax_load.js":1,"sites\/all\/modules\/custom\/aspe_book\/theme\/js\/aspe_book.filtering.js":1,"sites\/all\/modules\/custom\/aspe_book\/theme\/js\/aspe_book.collapsible.js":1,"profiles\/openpublic\/modules\/contrib\/field_group\/field_group.js":1,"sites\/all\/themes\/stability\/vendor\/jquery-migrate-1.2.1.min.js":1,"sites\/all\/themes\/stability\/vendor\/bootstrap.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flexnav.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.hoverIntent.minified.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flickrfeed.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.sloppy-masonry.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.imagesloaded.min.js":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/jquery.magnific-popup.js":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.fitvids.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.appear.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.stellar.min.js":1,"sites\/all\/themes\/stability\/vendor\/snap.svg-min.js":1,"sites\/all\/themes\/stability\/js\/custom.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/aspe.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/html5shiv.min.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/main-menu.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/keyboard-control.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tabBehavior.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tileStringTrimmer.js":1}},"webform":{"conditionals":{"webform-client-form-158521":{"ruleGroups":[],"sourceMap":[],"values":[]}}},"ajax":{"edit-webform-ajax-next-158521":{"callback":"webform_ajax_callback","wrapper":"webform-ajax-wrapper-158521","progress":{"message":"","type":"throbber"},"event":"click","url":"\/system\/ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Next \u003E"}}},"urlIsAjaxTrusted":{"\/system\/ajax":true,"\/report\/performance-improvement-1998\/food-and-drug-administration-0":true},"extlink":{"extTarget":"_blank","extClass":0,"extLabel":"(link is external)","extImgClass":0,"extSubdomains":0,"extExclude":"([a-z0-9]\\.gov)","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":"_blank","extAlertText":"This website contains links to other federal and state agencies and private organizations. The Department of Health and Human Services (HHS) cannot attest to the accuracy of information provided by these nonfederal website links. Linking to nonfederal sites does not constitute an endorsement by HHS or any of its employees of the sponsors or the information and products presented on the sites. You will be subject to the destination site\u0027s privacy policy when you leave the ASPE website.\r\n\r\nThank you for visiting aspe.hhs.gov!","mailtoClass":0,"mailtoLabel":"(link sends e-mail)"},"stability":{"flickr_id":"52617155@N08","logo_sticky":"28"},"jquery_ajax_load":{"trigger":".jquery_ajax_load","target":"#jquery_ajax_load_target","toggle":true,"animation":true,"base_path":"\/","module_path":"sites\/all\/modules\/custom\/aspe_book","site_name":"ASPE"},"field_group":{"div":"full"}});
//--><!]]>
</script>
  <script type="text/javascript">
<!--//--><![CDATA[//><!--
var addthis_config={pubid:"ra-5486d15a696bff0c",ui_click:false}
//--><!]]>
</script>


  <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"e4837db659","applicationID":"10708002","transactionName":"MwNaZBRSXEtXB0BdWQpJbUIPHFtWUgFMGkYMFg==","queueTime":0,"applicationTime":25,"atts":"H0RZElxIT0U=","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
